发明申请
- 专利标题： Compounds for the Treatment of Hepatitis C
- 专利标题（中）： 用于治疗丙型肝炎的化合物
-
申请号： US13210776申请日： 2011-08-16
-
公开(公告)号： US20120213729A1公开(公告)日： 2012-08-23
- 发明人: Li-Qiang Sun , Eric Mull , Qian Zhao , Tao Wang , Zhongxing Zhang , Paul Michael Scola
- 申请人： Li-Qiang Sun , Eric Mull , Qian Zhao , Tao Wang , Zhongxing Zhang , Paul Michael Scola
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 主分类号： A61K31/53
- IPC分类号： A61K31/53 ; A61K38/21 ; A61K38/13 ; A61K31/541 ; A61K31/5377 ; C07D403/04 ; C07D413/12 ; C07D251/52 ; C07D403/12 ; C07D401/14 ; C07D401/12 ; A61P31/14 ; A61K38/20 ; C07D417/12
摘要：
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
公开/授权文献
- US08765944B2 Compounds for the treatment of hepatitis C 公开/授权日：2014-07-01
信息查询
